G. Critchi

Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial

P. Flamen, F. Rothé, E. Trevisi, 2020, Cancers.

68Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy

P. Flamen, M. Paesmans, T. Gil, 2021, The Journal of Nuclear Medicine.

Prognostic value of a three-scale grading system based on combining molecular imaging with 68Ga-DOTATATE and 18F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias

P. Flamen, A. Hendlisz, G. Machiels, 2020, Oncotarget.

Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer

P. Flamen, L. Ameye, F. Sclafani, 2021, The Journal of Nuclear Medicine.

Treatment priorities in oncology: do we want to live longer or better?

E. Saad, M. Kovács, G. Marta, 2014, Clinics.

Living better or living longer? Perceptions of patients and health care professionals in oncology

R. Riechelmann, E. Saad, P. Hoff, 2015, Ecancermedicalscience.

Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study

P. Flamen, L. Ameye, B. Vanderlinden, 2023, The Journal of Nuclear Medicine.